Showing 291-300 of 1780 results for "".
Starting a Practice: Choosing Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/starting-a-practice-choosing-devices/18900/In his new series for Modern Aesthetics® Magazine, Christopher Khorsandi, MD offers tips for aesthetic physicians opening or expanding a practice. In this edition he discusses device selection and integration with an emphasis on marketing and patient conversion.New In My Practice: Rx
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-rx/23242/How Ironic Is Iconic?
https://practicaldermatology.com/series/editors-message/how-ironic-is-iconic/23859/Tips for Filling the Jaw, Chin, and Mid-face
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tips-for-filling-the-jaw-chin-and-mid-face/23598/CSF faculty members share pearls for injecting new fillers.11 Easy Steps to Avoid a MIPS Penalty in 2019 … Without an EHR or a Registry
https://practicaldermatology.com/topics/practice-management/11-easy-steps-to-avoid-a-mips-penalty-in-2019--without-an-ehr-or-a-registry/20598/Follow this advice to save four percent in 2019.New Products
https://practicaldermatology.com/columns/new-products/new-products/20885/DermWireTV: Derm Salaries Down, Allergan Eyes Soliton, Emsculpt Week
https://practicaldermatology.com/topics/practice-management/dermwiretv-derm-salaries-down-allergan-eyes-soliton-emsculpt-week/19941/Just under half of all physicians in the US are employed in physician-owned medical practices, new data from the American Medical Association show. Medscape’s annual Physician Compensation Report reveals that physicians overall saw a reduction in income due to the COVID-19 pandemic; income for dermDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)Digital Photomapping (DPM) in Mohs
https://practicaldermatology.com/topics/general-topics/digital-photomapping-dpm-in-mohs/20682/Therapeutics Focus: Corticosteroids
https://practicaldermatology.com/topics/psoriasis/therapeutics-focus-corticosteroids/21432/New products and pharmacologic developments